UK

Umesh Kumar Gupta

Director Director DIN 00980080
DIN 00980080 First appointment Mar 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2004
Shareholding value •••• Premium profile

About Umesh Kumar Gupta

Data last updated:

Umesh Kumar Gupta was a Director at Medipol Pharmaceutical India Private Limited (2004–2025) and Director at Wellgen Biotech Private Limited (2022–2024). The companies operate in Pharma.

DIN 00980080
Primary Designation Director
Industry Pharma
First Appointment 01 Mar 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20041992₹49.73 Cr (FY 2025)Active
Wellgen Biotech Private Limited U24290DL2022PTC393078
Director31 Jan 20222022₹4.00 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medipol Pharmaceutical India Private Limited
Wellgen Biotech Private Limited
Premium access

Shareholding and investment profile for Umesh Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umesh Kumar Gupta

Umesh Kumar Gupta was first appointed on 01 Mar 2004 as Director at Medipol Pharmaceutical India Private Limited. The most recent appointment on record is 31 Jan 2022 at Wellgen Biotech Private Limited.

Umesh Kumar Gupta held 2 earlier board appointments: Medipol Pharmaceutical India Private Limited (Director, 01 Mar 2004 to 01 Dec 2025); Wellgen Biotech Private Limited (Director, 31 Jan 2022 to 10 Feb 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available